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Polyethylene glycol (PEG) has been previously shown to protect against enteric pathogens and prevent colon cancer invasion. To
determine if PEG could indeed protect against previously observed pro-invasive eﬀects of commensal E. coli and EPEC, Caco-2
cells grown in an in vitro model of colon cancer were infected with strains of human commensal E. coli or EPEC and treated
with 10% PEG 3350, PEG 8000, and PEG 20,000, respectively. At 24 hours after infection, MMP-1 and MMP-13 activities, cell
cluster thickness, depth of invasion, and proliferation were determined using standard molecular biology techniques and ad-
vancedimaging.WefoundthathighermolecularweightPEG,especially PEG8000and20,000,regardless ofbacterial infection,in-
creased proliferation and depth of invasion although a decrease in cellular density and MMP-1 activity was also noted. Maximum
proliferation and depth of invasion of Caco-2 cells was observed in scaﬀolds treated with a combination of commensal E. coli
strain, HS4 and PEG 8000. In conclusion, we found that PEG 8000 increased cell proliferation and led to the preservation of cell
density in cells treated with commensal bacteria. This is important, because the preservation of a proliferative response in colon
cancer results in a more chemo-responsive tumor.
1.Introduction
Colon cancer remains the third leading cause of cancer mor-
tality worldwide [1]. Colon cancers are unique in so far as
they arise in a microenvironment teaming with bacteria. In
the absence of colorectal cancer or colonic inﬂammation, in-
testinal bacteria are involved in the promotion of nutrition,
lymphoid development, competition with pathogenic bacte-
ria, and with tissue repair [2–5]. They may also play a role in
oncologic surveillance and induce apoptosis to prevent ab-
normal colonic proliferation [6].
The symbiotic relationship between the cells of the
colon and the commensal bacteria adjacent to them is
normally maintained by ﬁve major “ﬁrewalls.” These are the
mucus layer atop of the epithelial cells [7, 8], the epithelia
themselves, subepithelial macrophages, dendritic cells, and
mesenteric lymph nodes [9]. However, with the occurrence
of colon cancer, barrier function between the epithelial
cells and commensal bacteria surrounding them is lost. As
such, these previously noninvasive bacteria gain the ability
to invade into the epithelial layer both enzymatically and
nonenzymatically, further disrupting cellular function.
Polyethylene glycol (PEG) is used clinically to treat
chronicconstipationandtoprepindividualsforcolonoscopy
and various other gut imaging procedures [10, 11]. PEG has
been used as a vehicle to successfully deliver chemotherapy
in an in vitro murine model of colon cancer [12]. Recently,
it has been noted that PEG has profound chemopreventive
properties in both experimental models of colon carcino-
genesis [13] and in human population studies [14]. PEG’s
ability to act as a chemo-preventive agent is most likely due
toitsabilitytoinduceapoptosisindamagedcells[13,15,16].2 Journal of Biomedicine and Biotechnology
Furthermore,PEGhasalsobeenshowntoreinforceepithelial
barrier function in the colon in experimental models of
colitis [17]. PEG molecules have been known to adhere to
proteins and surfactant phospholipids thereby forming bar-
rier-like structures [18–20].
While the most widely available form of PEG is the mol-
ecular weight of 3350, both high and low molecular weight
forms of PEG have been shown to be of potential clinical
importance. For example, PEG 15–20, a low molecular
weight PEG, has been shown to protect against radiation-in-
duced intestinal injury via its ability to bind lipid rafts and
prevent their coalescence [21]. Further, PEG 8000 has de-
monstrated functionality as a barrier inhibiting interactions
between colonizing microbes and their epithelial cell targets,
thereby forming a mucin-like layer [22].
Underspeciﬁcconditionsthecommensalbacterialstrains
a r ea b l et oo v e r c o m ep r o t e c t i v eh o s tr e s p o n s e sa n de x e r t
pathologic eﬀects that may aid in the onset of colon cancer
[23]. Pathogenic E. coli strains, speciﬁcally Enteropathogenic
E. coli (EPEC), have been known to attach to intestinal epi-
thelial cells and cause epithelial cytoskeletal changes and dis-
ruption of surrounding microvilli [24]. Similarly, the inva-
sivecharacteristics ofmalignant colonicepitheliafurther dis-
rupt the gut barrier function in the event of colon cancer.
On the basis of the literature to date, we hypothesized
that PEG might also help restore the symbiotic relationship
between commensal bacteria and malignant colonic epithe-
lia, thereby decreasing their proinvasiveness with the occur-
renceofcoloncancer.Totestthis,weutilizedaninvitrocolon
cancer model, PEG of various molecular weights (MW 3350,
8000, and 20,000) and both commensal and pathogenic
bacteria as described below.
2.ExperimentalProcedures
2.1.Reagents and Supplies. Allcell culturereagentsexcluding
fetal bovine serum (FBS), from Gemini Bio-products (West
Sacramento, Calif, USA), were obtained from Mediatech,
Inc. (Herndon, VA). Caco-2 cells were purchased from
ATCC. Cells were maintained in dishware from BD Falcon
(Lincoln Park, NJ, USA). Type I rat tail collagen was pur-
chased from BD Bioscience (Bedford, Mass, USA). MTT as-
say components and phalloidin was obtained from Invitro-
gen(Carlsbad,Calif,USA).Allothersuppliesweremolecular
biology grade and were from Fisher Scientiﬁc (Pittsburg, PA,
USA).
2.2.Cell Culture. Caco-2cellswereculturedinD-MEM/F-12
50/50 1X with L-glutamine and 15mM HEPES supplement-
ed with 10% fetal bovine serum and were incubated at 37◦C
in a 5% CO2 atmosphere.
2.3. Creation of 3D Scaﬀolds. Type I collagen gel scaﬀolds
werecreatedandseededwithcells.TypeIcollagenwasplaced
into a solution of 0.1M sodium hydroxide combined with
10X Hanks buﬀered salt solution (HBSS). Media was added
to this mixture and then was neutralized using 0.1M acetic
acid to create a gel of 1.2mg/mL. 800µL of the collagen gel
mixture was placed into each well of a 12-well plate and
incubated for one hour prior to seeding. Cells were seeded
at a density of 250.000 cells/cm2.
2.4. Infection of Scaﬀolds. Scaﬀolds were infected with either
commensal or pathogenic E. coli strains. Bacteria were
grown overnight in LB Broth on a bacterial shaker at 37◦C.
1mL of bacterial culture was added to 5mL of serum-
free media and placed on a shaker at 37◦C for two hours.
Bacterial concentration was determined by measuring the
optical density (OD) at 600nm. Bacteria were added to the
scaﬀolds at an MOI = 30 per cell in serum-free DMEM/F-12.
Samples were then incubated at 37◦C for two hours. Bacteria
containing media was then removed and the scaﬀolds were
treated with gentamicin at a concentration of 50µg/mL
for two hours. Following removal of antibiotic containing
media, scaﬀolds were incubated overnight in fresh serum-
free media containing 10µg/mL gentamicin.
2.5. Multiphoton Microscopy. Multiphoton imaging holds
inherent advantages for imaging living tissues by improving
depth penetration and reducing photodamage [25]. Two-
photon or multiphoton imaging allows the mapping of
ﬂuorophore distribution inside tissue down to a depth of
over500µm providing subcellularleveltissue morphological
information. Samples were seeded onto 1.2mg/mL concen-
tration type I collagen with an approximate scaﬀold thick-
ness of 5mm and imaged using multiphoton microscopy.
Cells were seeded onto scaﬀolds and infected according
to the protocol mentioned before. Scaﬀolds were then
washed with phosphate buﬀered saline (PBS), ﬁxed over-
night with 10% neutral buﬀered formalin. Scaﬀolds were
then blocked for 30 minutes with serum free protein block
andstainedforactinusingphalloidin.Scaﬀoldswerethenin-
cubated with 300nM DAPI in PBS for 5 minutes to stain
nuclei.
Seeded cells and actin cytoskeleton were imaged by a
laserscanning multiphotonconfocalmicroscopewith 60xoil
objective (NA = 1.40). DAPI was visualized by using multi-
photon laser excitation at 700nm and emission at 450nm,
for which the femtosecond laser beam (80MHz, 0.5mW)
pumped from a mode-locked titanium sapphire laser
(MaiTai, Spectra-Physics Inc., Calif, USA), was coupled with
visible laser (Bio-Rad, UK) into an inverted laser scanning
confocal microscope (Nikon TE200-U, Japan). Reﬂection
signals from the collagen ﬁbers were excited and acquired at
a wavelength of 488nm.
2.6. Multiphoton Image Analysis. Multiphoton images were
analyzed to determine depth of invasion, cluster thickness,
and cluster density.
To determine depth of invasion, commercially available
software, Lasersharp 2000, was used. Brieﬂy, the lowest point
with actin (red) and DAPI (blue)staining within the scaﬀold
was measured for each sample.
To determine the cluster thickness, the multiphoton
images were tilted to visualize the scaﬀold in z-direction.
The thickness was determined by measuring a portion of the
scaﬀold where the cells were most densely packed.Journal of Biomedicine and Biotechnology 3
To measure the cluster density, the number of cells were
counted in a 100µm × 100µm area within the scaﬀold.
2.7. Proliferation Assay. Cell proliferation was determined
using a standard MTT assay kit. To determine the degree
of proliferation following treatment with commensal E. coli
strains, EPEC, or following treatment with each of the
various bacteria in the presence of PEG 3350, PEG 8000, or
PEG 20,000, we used a standard MTT assay. This particular
method is useful for determining proliferation in these types
of 3D cultures, because it does not require disruption of the
cells from their scaﬀold. Each experiment was performed a
minimum of three times.
Allcomponentsusedwerefree ofphenolred,since itmay
interfere with the accuracy of the assay. To do this, the media
was removed from each chamber and the gels were washed
with PBS. 100µLf r e s hm e d i aa n d2 0µL of dye ((3-(4,5-dim-
ethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in PBS
was added to each chamber. The gels were incubated at 37◦C
for four hours. After four hours, 50µLf r o me a c hc h a m b e r
wasaddedto100µLofdimethylsulfoxide(DMSO)inasmall
vial and incubated for ﬁfteen minutes. Absorbance readings
were taken at 550nm for each sample to determine the cell
proliferation values.
2.8. Matrix Metalloprotease Activity. MMP-1 and 13 activi-
ties were determined using a commercially available ﬂuoro-
metric assay designed to quantitatively measure enzyme ac-
tivity. Brieﬂy a monoclonal antibody speciﬁc for each MMP-
1 or MMP-13 was precoated onto a microplate. Standards
and samples were placed into the wells, and the MMP of
interest wasbound by theimmobilized antibody. Afterwash-
ingawayunboundsubstances, anactivationreagent(APMA)
was added to standards and samples. Following a wash, a ﬂu-
orogenic substrate linked to a quencher molecule is added.
Active enzymes cleave the peptide linker between the ﬂu-
orophore and the quencher molecule. A ﬂuorescent signal
proportional to the amount of enzyme activity is produced
due to this cleavage.
3.Results
3.1. Higher MW PEGs Increase Proliferation. Cellular prolif-
eration increased slightly over control in response to the
two commensal E. coli strains, 264 and HS4 (Figure 1). Spe-
ciﬁcally, proliferation increased 1.2-fold in response to treat-
ment with strain 261 and 1.5-fold in response to treatment
with HS4. HS4 bacterial strain by itself increased prolifera-
tion. However, proliferation was attenuated by incubation of
the cells with EPEC that led to a reduction in cellular pro-
liferation as compared with control by nearly two thirds.
PEG 8000 and PEG 20,000 alone increased cell prolifera-
tion four and three fold over control, respectively. Treatment
with PEG 3350 did not signiﬁcantly alter proliferation.
When cells were treated with bacteria and PEG, cellular
proliferation increased signiﬁcantly. Speciﬁcally, combina-
tion of PEG 8000 and HS4 increased proliferation by six-
fold and combination of HS4 with PEG 20,000 increased
proliferation twofold. Proliferation remained constant when
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Figure 1: PEG 8000 increases proliferation of Caco-2. Proliferation
of cells on the scaﬀold was observed using MTT proliferation assay
as described in Methods. Higher molecular weight PEGs, 8000
and 20,000, increased proliferation regardless of bacterial infection.
Maximumproliferationwasnotedwhencellsweretreated withHS4
and PEG 8000. Standard Student’s t-test was applied to the samples
and P<0.05 were obtained for samples treated with PEG 8000 and
HS4 indicated by an asterisk (∗).
treated with PEG 3350 regardless of bacterial strain
(Figure 1).
3.2. Higher MW PEGs Decrease Cell Cluster Thickness. As de-
scribed in the methods section of this paper, cell cluster
thickness refers to the bulk of cells in a scaﬀold. In collagen
scaﬀolds infected with both bacterial strains and PEG 8000
cells were more dispersed and were not as tightly packed as
seen in the control scaﬀolds treated with PEG 8000 alone).
This was particularly true when samples were infected with
HS4 (Figure 2). Collagen scaﬀolds were divided into approx-
imately 16 stacks (each stack was approximately 5µm) to
better visualize the penetration depth. In the control sample,
which was treated with PEG 8000 alone, cells penetrated
to approximately 10 stacks (∼50µm). When incubated with
bacterial strain 261, decreased cluster thickness to approx-
imately 8 stacks (40µm). When infected with bacterial stain
HS4, cluster thickness remained fairly constant in spite of
higher proliferation rate (Figure 1).
Cell cluster thickness decreased when treated with dif-
ferent molecular weight PEG (Figure 3). The control sample
where no PEG was added, the cluster thickness was approx-
imately 100µm. When samples were treated with PEG 3350,
the cluster thickness decreased to approximately 70µm, and
when treated with PEG 8000, the cluster thickness decreased
to approximately 50µm.
3.3. Quantitative Analysis of Depth of Invasion. As described
in the methods section of this paper, depth of invasion refers
to how far the cellspenetrate into thescaﬀold. The diﬀerence
between this and cell cluster thickness is that in depth of
invasion describes the lowest point in the scaﬀold at which
the cellular signal is detected. The quantiﬁcation of depth4 Journal of Biomedicine and Biotechnology
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Figure 2: Multiphoton images of Caco-2 cells treated with PEG 8000 and various bacterial strains. Uninfected cells were served as control
(a). Caco-2 cells were infected with commensal strains, 261 and HS4 (b, c), and EPEC (d). The maximum depth of invasion was seen in
scaﬀolds infected with HS4. The overall thickness of the scaﬀold was approximately 400µm. The actin ﬁlaments are shown in red and the
DAPI staining of nuclei are shown in blue. Bar length = 10µm.
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Figure 3: Multi-photon Images of Caco-2 cells treated with various molecular weight PEGs (a) Untreated cells were served as control. (b, c)
Caco-2 cells were treated with PEG 3350 and PEG 8000 respectively. Cluster thickness decreased when treated with higher molecular weight
PEG. The cluster thickness when treated with PEG 8000 was approximately 50µm. The actin ﬁlaments are shown in red and DAPI staining
of nuclei is in blue. Bar length=20µm.
of invasion is essential in determining the proinvasive eﬀect
of each of the variables on Caco-2 cell behavior. In the data
presented above, it appears that Caco-2 cells may be more
aggressive when treated with higher molecular weight PEG
and the commensal bacterial strain, HS4 (Figures 1 and 2).
A threefold increase in cell penetration depth was ob-
served in samples infected with either commensal or path-
ogenic bacteria alone. Also, higher molecular weight PEG
alone, especially PEG 8000, increased depth of invasion by
twofold (Figure 4).Journal of Biomedicine and Biotechnology 5
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Figure 4: Quantitative analysis of depth of invasion. Depth of
invasion was analyzed as described in Methods. All three PEGs and
allthreebacterial strainsindependentlyincreaseddepth ofinvasion.
A decrease in invasion was noted when samples were treated with
PEG 3350 and either 261 or EPEC. Treatment with any bacterial
strainand eitherPEG 8000 orPEG20,000 led to increased invasion.
The greatest increase was seen when samples were treated with PEG
8000 and HS4. Standard Student’s t-test was applied to the samples
and the P<0.05 were obtained for samples treated with PEG 8000
and HS4 indicated by an asterisk (∗).
Samples exposed to both PEG and bacterial condition
slightly increased the invasion depth of Caco-2 cells com-
pared to samples exposed to PEG or bacteria alone. Maxi-
mum invasion of 65µm was observed in samples treated
with PEG 8000 and infected with HS4.
3.4. Quantitative Analysis of Cell Density. As described in
the methods section of this paper, cell density refers to the
number of cells within a given area. The diﬀerence between
thisandcellclusterthicknessisthatcelldensityisthenumber
of cells within a 100mm × 100mm (both in Z and Y di-
rections) scaﬀold matrix whereas cell cluster thickness was
measured in Z-direction only.
Each bacterial strain and each PEG, when observed
independently, signiﬁcantly reduced the number of cells in
a given area (Figure 5). This was particularly true when cell-
containing scaﬀolds were infected with the commensal E.
coli, HS4. Speciﬁcally, a sixfold reduction in cell density was
observed. Cell density in samples infected with either 261 or
EPECwasreducedby50%relativetocontrol.Treatmentwith
either PEG 3350 or PEG 8000 led to similar reduction in cell
density, whereas treatment with PEG 20,000 decreased the
cell density by approximately 50%.
The combination of PEG with bacterial strains increased
celldensity.Thiswasparticularly truewhen cellsweretreated
with a combination of PEG 8000 and HS4, which led to a
threefold increase in cell density when compared to samples
infected with HS4 alone (Figure 5).
3.5. PEG 8000 Decreases MMP-1 Activity in Cells Expose to
Commensal and Pathogenic E. coli. Since MMP-1 is involved
in the initial breakdown of collagen during tumor growth
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Figure 5: Quantitative analysis of cluster density. Cell density
analysis was performed as described in Methods. Cell density de-
creased in response to independent treatment with any of the three
PEGs or bacterial strains. When treated with PEG 3350 and the two
commensal bacterial strains, there was an increase in cell density.
Cell density recovery was most persevered when treated with PEG
8000 and HS4. PEG 20,000 did not preserve cell density when
cells were treated with any of the three bacterial strains. Standard
Student’s t-test was applied to the samples and the P<0.05 were
obtained for samples treated with PEG 8000 and HS4 indicated by
an asterisk (∗).
and invasion [26], an increase in collagenase activity is ex-
pected when cells become more invasive. In our model sys-
tem, PEG 3350 and PEG 20,000 increased MMP-1 activity
in uninfected samples. However, a decrease in MMP-1 ac-
tivity was observed when samples were treated with PEG
8000 alone. Infecting with bacterial strains alone did not sig-
niﬁcantly reduce MMP-1 activity. However, treating samples
with a combination of PEG and any of the two commensal
bacterial strains, 261 and HS4, reduced MMP-1 activity
signiﬁcantly. Speciﬁcally, a greater than twelvefold decrease
in MMP-1 activity was observed in samples infected with
commensal bacterial strain (HS4 or 261) and treated with
PEG 3350 orPEG 8000(Figure 6). While PEG 3350 and PEG
20,000 did lead to a slight decrease in MMP-1 activity during
EPEC infection, only PEG 8000 led to a true decrease in
activity, which was nearly ﬁvefold over control.
3.6. PEG Has No Eﬀect on MMP-13 Activity. No signiﬁcant
change in MMP-13 activity was observed when infected with
commensal and pathogenic E. coli strains alone. A slight
increase in MMP-13 activity was observed in samples treated
with PEG alone. This was especially true when samples were
treated with PEG 20,000 (Figure 7). Infection with com-
mensal bacteria orEPEC slightly decreasedMMP-13 activity.
This was not statistically signiﬁcant.
4.Discussionand Conclusion
In this study, we demonstrated that cell proliferation and
depth of invasion were most increased when treated with
higher molecular weight PEGs and commensal bacteria.
These ﬁndings were somewhat surprising to us but were6 Journal of Biomedicine and Biotechnology
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Figure 6: MMP-1 Activity of Caco-2 cells infected with commensal
and pathogenic bacteria and treated with 10% PEG. MMP-1 ac-
tivity in cells treated with commensal bacterial strains were com-
paratively lower than when infected with pathogenic (EPEC). PEG
signiﬁcantly reduced the MMP-1 activity when infected with bac-
teria (both commensal and pathogenic). A 12-fold decrease in
MMP-1 activity was noted in samples treated with PEG 8000 and
infected with commensal bacteria. Standard Student’s t-test was
applied to the samples and the P<0.05 were obtained for samples
treated with PEG 8000 and HS4 indicated by an asterisk (∗).
balancedbyourﬁndingofdecreasedclusterthickness,thatis,
adecreaseinthenumberofcellsinagivenareaanddecreased
MMP-1 activity. We hypothesize that this occurred because
of the structural properties of these higher molecular weight
PEGs rather than because of their molecular weight per se.
The structural properties of PEG act by increasing the
volume of macromolecules surrounding the cells. Increasing
the amount of macromolecules surrounding the cells aids in
the formation of bundled F-actin [27]. Also, in the presence
of inert macromolecular “crowders” it has been shown that
the association rate constant of actin monomers to an actin
ﬁlament increases [28]. Furthermore, the bundling of actins
has been shown to increase proliferation in colonic epithelial
cells [29]. Hence, it is safe to assume that the overcrowding
caused by PEG molecules aids in actin bundling which in
turn increases the proliferation rate of Caco-2 cells. The
proliferative response we observed in this in vitro model
in response to the two commensal strains of E. coli and to
EPEC is consistent with previously published results [30].
The slight reduction in proliferation in response to EPEC is
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Figure 7: MMP-13 activity for Caco-2 cells infected with com-
mensal and pathogenic bacteria and treated with 10% PEG.
There was no change in MMP-13 activity in samples treated with
either PEG 3350 or PEG 8000 as compared to control regardless
of infection status. Infection with commensal bacteria or EPEC
slightly decreased the MMP-13 activity. This was not statistically
signiﬁcant.StandardStudent’s t-test wasapplied to the samplesand
the P<0.05 were obtained for samples treated with PEG 8000 and
HS4 indicated by an asterisk (∗).
also not surprising considering that EPEC is known to cause
cellular apoptosis [31–33].
With the increased in cell proliferation, an increase in
depth of invasion of Caco-2 cells was also observed. But
this is not important and is merely reﬂective of increased
proliferation. What is more important is that cell cluster
thickness decreased in response to a high molecular weight
PEG milieu. This is critical, because the cells are packed
moretightly.Inotherwords, thereisevidencesuggestingthat
gut barrier function is being restored by higher molecular
weight PEGS, particularly PEG 8000. This is supported by
a recent study in a rat colitis model that demonstrated that
PEG increased colonic surface hydrophobicity, diminished
luminal bacterial load, and reduced chemically induced
mucosal damage and inﬂammation [17].
In summary, we have demonstrated that a signiﬁcant
increase in proliferative response occurs in an in vitro colon
cancer model when treated with PEG 8000 and commensal
E. coli strains. Our ﬁnding suggests that PEG 8000 may
potentially be a valuable therapeutic agent that could be
used in conjunction with standard chemotherapy. Further
studies will be needed to understand the protective role
of high molecular weight PEGs, particularly PEG 8000, in
colon cancer and their potential for making tumors more
chemosensitive by increasing cell proliferation.
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